Dr. Makker on Synergy Between Lenvatinib and Pembrolizumab in Endometrial Cancer

3 Bekeken
administrator
administrator
09/30/23

Vicky Makker, MD, medical oncologist, Memorial Sloan Kettering Cancer Center, discusses the synergy between lenvatinib and pembrolizumab in the treatment of patients with endometrial cancer.

  • categorie

Laat meer zien

0 Comments Sorteer op

Geen reacties gevonden

Facebook Reacties

Volgende